{"schema_version":"1","generated_at":"2026-11-18T09:44:44.886Z","data_as_of":null,"url":"https://www.findmykol.com/kol/natalyn-hawk","json_url":"https://www.findmykol.com/kol/natalyn-hawk/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"natalyn-hawk","name":"Natalyn Hawk","credential":"MD, PhD","specialty":"Hematology / Oncology","specialty_raw":"Hematology & Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"Eisai","institution_url":"https://www.findmykol.com/institution/eisai","city":"Atlanta","state":"GA","region":{"label":"Southeast","url":"https://www.findmykol.com/region/southeast"}},"identifiers":{"npi":"1700063831","openalex":"A5080508830"},"summary":"Natalyn Hawk is an Oncology physician affiliated with Eisai. OpenAlex indexes 40 publications with 899 citations (h-index 11); ClinicalTrials.gov lists 1 registered study matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":40,"cited_by_count":899,"h_index":11,"latest_activity_year":2026,"source":"works"},"trials":{"count":1,"shown":1,"withheld":0,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT01446458","title":"Phase I Study of Stereotactic Body Radiation Therapy and FOLFIRINOX in the Neoadjuvant Therapy of Pancreatic Cancer","phase":"PHASE1","status":"COMPLETED","role":"Overall official","sponsor":"Emory University","source_url":"https://clinicaltrials.gov/study/NCT01446458","trial_url":"https://www.findmykol.com/trial/NCT01446458"}],"source":"trials"},"publications":{"total":40,"shown":5,"withheld":35,"matched_by":"OpenAlex author record","recent":[{"title":"Open label, multicenter, phase 2 study of farletuzumab ecteribulin (FZEC), a folate receptor alpha (FRα)-targeting antibody-drug conjugate (ADC), alone and in combination with lenvatinib in platinum-resistant ovarian cancer (PROC)","year":2026,"journal":"Gynecologic Oncology","source_url":"https://doi.org/10.1016/j.ygyno.2026.01.306","status":"verified"},{"title":"Open label, multicenter, phase 2 study of farletuzumab ecteribulin, a folate receptor alpha-targeting antibody-drug conjugate, alone and in combination with lenvatinib in platinum-resistant ovarian cancer","year":2026,"journal":"International Journal of Gynecological Cancer","source_url":"https://doi.org/10.1016/j.ijgc.2025.104404","status":"verified"},{"title":"Farletuzumab ecteribulin, a folate receptor alpha (FRα) antibody-drug conjugate, in select advanced cancers: An open-label, multicenter, phase 1/2 dose-finding study","year":2026,"journal":"Gynecologic Oncology","source_url":"https://doi.org/10.1016/j.ygyno.2026.08.023","status":"verified"},{"title":"LEAP-014: first-line lenvatinib + pembrolizumab + chemotherapy in advanced/metastatic esophageal squamous cell carcinoma","year":2024,"journal":"Future Oncology","source_url":"https://doi.org/10.2217/fon-2022-1148","status":"verified"},{"title":"Abstract CT056: A multicenter, open-label phase 1/2 trial evaluating the safety, tolerability, and efficacy of MORAb-202, a folate-receptor-alpha-targeting antibody-drug conjugate in patients with selected tumor types","year":2023,"journal":"Cancer Research","source_url":"https://doi.org/10.1158/1538-7445.am2023-ct056","status":"verified"}],"source":"works"},"contact":{"address_1":"1365C CLIFTON RD NE","city":"Atlanta","state":"GA","zip":"303221013","phone":"404-731-6365","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1700063831","source":"identity"},"similar":[{"name":"Michael Irizarry","slug":"michael-irizarry","institution":"Eisai","specialty":"Neurology","url":"https://www.findmykol.com/kol/michael-irizarry","json_url":"https://www.findmykol.com/kol/michael-irizarry/profile.json"},{"name":"Corina E. Dutcus","slug":"corina-dutcus","institution":"Eisai","url":"https://www.findmykol.com/kol/corina-dutcus","json_url":"https://www.findmykol.com/kol/corina-dutcus/profile.json"},{"name":"Toshiyuki Matsuoka","slug":"toshiyuki-matsuoka","institution":"Eisai","url":"https://www.findmykol.com/kol/toshiyuki-matsuoka","json_url":"https://www.findmykol.com/kol/toshiyuki-matsuoka/profile.json"},{"name":"Yasuhiro Funahashi","slug":"yasuhiro-funahashi","institution":"Eisai","url":"https://www.findmykol.com/kol/yasuhiro-funahashi","json_url":"https://www.findmykol.com/kol/yasuhiro-funahashi/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Stuart Orkin","slug":"stuart-orkin","institution":"Harvard Medical School","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/stuart-orkin","json_url":"https://www.findmykol.com/kol/stuart-orkin/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"publications":35}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2008-01-31","collected_at":"2026-11-06T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"}},"methodology_url":"https://www.findmykol.com/about#methodology"}